Dear Users,

The journal ratings for Impact Factor 2024 have been published.

https://jcr.clarivate.com

GINOP-2.3.2-15-2016-00024

Az irányított és transzpozon-mediált génbevitel molekuláris kutatása a biztonságosabb génterápia érdekében

start date: 2016-01-01

end date:

Publication list

statistics filterable publication list

Upload publications

Uploaded publications:

Publications in DEA:

OA:

Date range:

2017-2023

2023

Imre, G., Takács, B., Czipa, E., Drubi, A. B., Jaksa, G., Latinovics, D., Nagy, A., Karkas, R., Hudoba, L., Vásárhelyi, B. M., Pankotai-Bodó, G., Blastyák, A., Hegedűs, Z., Germán, P., Bálint, B., Ahmed Abdullah, K. S., Kopasz, A. G., Kovács, A., Nagy, L. G., Sükösd, F., Pintér, L., Rülicke, T., Barta, E., Nagy, I., Haracska, L., Mátés, L.: Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy.
Molecular Therapy - Methods & Clinical Development. 29, 145-159, 2023.

doi DEA Scopus

Journal metrics:

Q1 Genetics

Q1 Molecular Biology

Q1 Molecular Medicine

2022

Suta, M. J., Béres, M., Csámer, L., Csik, A., Hegedűs, C.: Evaluation of Polyjet and SLA 3D printers.
Fogorv. Sz. 115 (2), 64-68, 2022.

doi DEA

Karányi, Z., Mosolygó, Á., Feró, O., Horváth, A., Boros-Oláh, B., Nagy, É., Hetey, S., Holb, I., Szaker, H., Miskei, M., Csorba, T., Székvölgyi, L.: NODULIN HOMEOBOX is required for heterochromatin homeostasis in Arabidopsis.
Nat Comms. 13, 1-20, (article identifier: 5058), 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Chemistry (miscellaneous)

D1 Physics and Astronomy (miscellaneous)

2021

Miskei, M., Horváth, A., Viola, L., Varga, L., Nagy, É., Feró, O., Karányi, Z., Roszik, J., Miskey, C., Ivics, Z., Székvölgyi, L.: Genome-wide mapping of binding sites of the transposase-derived SETMAR protein in the human genome.
Computational and Structural Biotechnology Journal. 19, 4032-4041, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

D1 Biophysics

Q1 Biotechnology

Q1 Computer Science Applications

Q1 Genetics

Q2 Structural Biology

Szabó, Z., Hornyák, L., Miskei, M., Székvölgyi, L.: Two targets, one hit: new anticancer therapeutics to prevent tumorigenesis without cardiotoxicity.
Front. Pharmacol. 11, 1-5, (article identifier: 569955), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

2020

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A. V., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, (article identifier: 310), 2020.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

Karányi, Z., Hornyák, L., Székvölgyi, L.: Histone H3 lysine 56 acetylation is required for formation of normal levels of meiotic DNA breaks in S. cerevisiae.
Front. Cell. Dev. Biol. 7, 1-18, 2020.

doi DEA

Journal metrics:

Q1 Cell Biology

Q1 Developmental Biology

Molnár-Fodor, K., Dobos, N., Schally, A. V., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

doi DEA

Journal metrics:

Q2 Oncology

2019

Boros-Oláh, B., Dobos, N., Hornyák, L., Szabó, Z., Karányi, Z., Halmos, G., Roszik, J., Székvölgyi, L.: Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy.
DNA Repair. 84, 1-10, (article identifier: 102642), 2019.

doi DEA Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

Q1 Molecular Biology

2018

10.

Hegedűs, É., Kókai, E., Nánási, P. P. i., Imre, L., Halász, L., Jossé, R., Antunovics, Z., Webb, M. R., El Hage, A., Pommier, Y., Székvölgyi, L., Dombrádi, V., Szabó, G.: Endogenous single-strand DNA breaks at RNA polymerase II promoters in Saccharomyces cerevisiae.
Nucleic Acids Res. 46 (20), 10649-10668, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Genetics

11.

Karányi, Z., Halász, L., Acquaviva, L., Jonás, D., Hetey, S., Boros-Oláh, B., Peng, F., Chen, D., Klein, F., Géli, V., Székvölgyi, L.: Nuclear dynamics of the Set1C subunit Spp1 prepares meiotic recombination sites for break formation.
J. Cell Biol. 217 (10), 3398-3415, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Cell Biology

D1 Medicine (miscellaneous)

12.

Hornyák, L., Dobos, N., Koncz, G., Karányi, Z., Páll, D., Szabó, Z., Halmos, G., Székvölgyi, L.: The role of indoleamine-2,3-dioxygenase (IDO) in cancer development, diagnostics, and therapy.
Front. Immunol. 9 (151), 1-8, (article identifier: 151), 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

2017

13.

Hetey, S., Boros-Oláh, B., Kuik-Rózsa, T., Li, Q., Karányi, Z., Szabó, Z., Roszik, J., Szalóki, N., Vámosi, G., Tóth, K. Á., Székvölgyi, L.: Biophysical characterization of histone H3.3 K27M point mutation.
Biochem. Biophys. Res. Commun. 490 (3), 868-875, 2017.

doi DEA

Journal metrics:

Q2 Biochemistry

Q1 Biophysics

Q3 Cell Biology

Q2 Molecular Biology

14.

Roszik, J., Fenyőfalvi, G., Halász, L., Karányi, Z., Székvölgyi, L.: In Silico Restriction Enzyme Digests To Minimize Mapping Bias In Genomic Sequencing.
Mol. Ther. Methods. Clin. Dev. 6, 66-67, 2017.

doi DEA

Journal metrics:

Q2 Genetics

Q2 Molecular Biology

Q2 Molecular Medicine

15.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 27, 1063-1073, 2017.

doi DEA

Journal metrics:

D1 Genetics

D1 Genetics (clinical)